GLP-1 Receptor Agonists and SGLT-2 Inhibitors: A Dynamic Duo?
September 23, 2016 First clinical trial to study GLP-1 receptor
September 23, 2016
September 23, 2016 First clinical trial to study GLP-1 receptor
The GLP-1 agonist semaglutide is the latest diabetes therapy to
The GLP-1 receptor agonist lixisenatide has received US FDA approval
Results of the cardiovascular outcomes LEADER trial have shown the
CV outcomes data from the ELIXA trial have been published
The GLP-1 agonist liraglutide has been shown to significantly decrease
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Cardiometabolic Health Congress
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2023, Cardiometabolic Health Congress. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
